89 related articles for article (PubMed ID: 16054691)
1. Reduced expression of TGF beta1RII in agnogenic myeloid metaplasia is not due to mutation or methylation.
Hemavathy KC; Chang TH; Zhang H; Charles W; Goldberg A; Aithal S; Novetsky AD; Wang JC
Leuk Res; 2006 Jan; 30(1):47-53. PubMed ID: 16054691
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of growth factor production in the mechanism of fibrosis in agnogenic myeloid metaplasia.
Wang JC; Chang TH; Goldberg A; Novetsky AD; Lichter S; Lipton J
Exp Hematol; 2006 Dec; 34(12):1617-23. PubMed ID: 17157157
[TBL] [Abstract][Full Text] [Related]
3. Detection of aberrant gene expression in CD34+ hematopoietic stem cells from patients with agnogenic myeloid metaplasia using oligonucleotide microarrays.
Jones LC; Tefferi A; Vuong PT; Desmond JC; Hofmann WK; Koeffler HP
Stem Cells; 2005 May; 23(5):631-7. PubMed ID: 15849170
[TBL] [Abstract][Full Text] [Related]
4. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
Zhang Y; Fatima N; Dufau ML
Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
[TBL] [Abstract][Full Text] [Related]
5. Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines.
Osada H; Tatematsu Y; Sugito N; Horio Y; Takahashi T
Mol Carcinog; 2005 Dec; 44(4):233-41. PubMed ID: 16163707
[TBL] [Abstract][Full Text] [Related]
6. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
7. Hypermethylation of CXCR4 promoter in CD34+ cells from patients with primary myelofibrosis.
Bogani C; Ponziani V; Guglielmelli P; Desterke C; Rosti V; Bosi A; Le Bousse-Kerdilès MC; Barosi G; Vannucchi AM;
Stem Cells; 2008 Aug; 26(8):1920-30. PubMed ID: 18511598
[TBL] [Abstract][Full Text] [Related]
8. Constitutive expression of the FK506 binding protein 51 (FKBP51) in bone marrow cells and megakaryocytes derived from idiopathic myelofibrosis and non-neoplastic haematopoiesis.
Bock O; Neusch M; Büsche G; Mengel M; Kreipe H
Eur J Haematol; 2004 Apr; 72(4):239-44. PubMed ID: 15089760
[TBL] [Abstract][Full Text] [Related]
9. TGF-betaRII rescues development of small intestinal epithelial cells in Elf3-deficient mice.
Flentjar N; Chu PY; Ng AY; Johnstone CN; Heath JK; Ernst M; Hertzog PJ; Pritchard MA
Gastroenterology; 2007 Apr; 132(4):1410-9. PubMed ID: 17408644
[TBL] [Abstract][Full Text] [Related]
10. Expression of Caveolin-1 reduces cellular responses to TGF-beta1 through down-regulating the expression of TGF-beta type II receptor gene in NIH3T3 fibroblast cells.
Lee EK; Lee YS; Han IO; Park SH
Biochem Biophys Res Commun; 2007 Jul; 359(2):385-90. PubMed ID: 17543885
[TBL] [Abstract][Full Text] [Related]
11. The expression of CSRP2 encoding the LIM domain protein CRP2 is mediated by TGF-beta in smooth muscle and hepatic stellate cells.
Herrmann J; Borkham-Kamphorst E; Haas U; Van de Leur E; Fraga MF; Esteller M; Gressner AM; Weiskirchen R
Biochem Biophys Res Commun; 2006 Jul; 345(4):1526-35. PubMed ID: 16735029
[TBL] [Abstract][Full Text] [Related]
12. Cooperation between GATA4 and TGF-beta signaling regulates intestinal epithelial gene expression.
Belaguli NS; Zhang M; Rigi M; Aftab M; Berger DH
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1520-33. PubMed ID: 17290010
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow angiogenesis and its clinical correlates in myelofibrosis with myeloid metaplasia.
Arora B; Ho CL; Hoyer JD; Mesa RA; Tefferi A
Haematologica; 2004 Dec; 89(12):1454-8. PubMed ID: 15590395
[TBL] [Abstract][Full Text] [Related]
14. Expression of TGF-beta1 and its receptor genes (TbetaR I, TbetaR II, and TbetaR III-betaglycan) in peripheral blood leucocytes in patients with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome.
Jachec W; Foremny A; Domal-Kwiatkowska D; Smolik S; Tomasik A; Mazurek U; Wodniecki J
Int J Mol Med; 2008 Jan; 21(1):99-107. PubMed ID: 18097622
[TBL] [Abstract][Full Text] [Related]
15. Loss of NECL1, a novel tumor suppressor, can be restored in glioma by HDAC inhibitor-Trichostatin A through Sp1 binding site.
Gao J; Chen T; Liu J; Liu W; Hu G; Guo X; Yin B; Gong Y; Zhao J; Qiang B; Yuan J; Peng X
Glia; 2009 Jul; 57(9):989-99. PubMed ID: 19062177
[TBL] [Abstract][Full Text] [Related]
16. Expression profiling of apoptosis-related genes in megakaryocytes: BNIP3 is downregulated in primary myelofibrosis.
Theophile K; Hussein K; Kreipe H; Bock O
Exp Hematol; 2008 Dec; 36(12):1728-38. PubMed ID: 18838203
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of HDAC inhibitor-induced thrombocytopenia.
Matsuoka H; Unami A; Fujimura T; Noto T; Takata Y; Yoshizawa K; Mori H; Aramori I; Mutoh S
Eur J Pharmacol; 2007 Oct; 571(2-3):88-96. PubMed ID: 17628529
[TBL] [Abstract][Full Text] [Related]
18. Progressive myelofibrosis in agnogenic myeloid metaplasia.
Lohmann TP; Beckman EN
Arch Pathol Lab Med; 1983 Nov; 107(11):593-4. PubMed ID: 6688716
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
[TBL] [Abstract][Full Text] [Related]
20. Repetitive exposure to TGF-beta suppresses TGF-beta type I receptor expression by differentiated osteoblasts.
Kim KK; Ji C; Chang W; Wells RG; Gundberg CM; McCarthy TL; Centrella M
Gene; 2006 Sep; 379():175-84. PubMed ID: 16806744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]